- Home
- Signaling Pathways
- GPCR/G protein
- 5-HT Receptor
- Lurasidone HCl
- Home
- Signaling Pathways
- Neuroscience
- 5-HT Receptor
- Lurasidone HCl
- Home
- Biochemical Reagent
- Signaling pathways
- Neuroscience
- Lurasidone HCl
- Home
- Biochemical Reagent
- Signaling pathways
- GPCR
- G Protein
- Lurasidone HCl
Lurasidone HCl
Catalog No.
B1477
Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor
Featured Products
Lurasidone Hcl (SM 13496 Hcl) is an inhibitor of Dopamine D2, 5-HT2A, 5-HT7, 5-HT1A and noradrenaline α2C with IC50 of 1.68 nM, 2.03 nM, 0.495 nM, 6.75 nM and 10.8 nM, respectively, which is an atypical antipsychotic.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 529.14 |
| Cas No. | 367514-88-3 |
| Formula | C28H37ClN4O2S |
| Solubility | insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL in DMSO with gentle warming |
| Chemical Name | (3aR,4R,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione hydrochloride |
| SDF | Download SDF |
| Canonical SMILES | Cl[H].O=C(C1([H])[C@](C([H])([H])C2([H])[H])([H])C([H])([H])C2([H])C13[H])N(C([H])([H])C4([H])C(C([H])([H])N5C([H])([H])C([H])([H])N(C6=NSC7=C6C([H])=C([H])C([H])=C7[H])C([H])([H])C5([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])C3=O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
